Mobile health interventions in preventive cardiology: contrasting implementation between Europe and Asia
-
By
-
Toshiki Kaihara
-
February 3, 2026
-
0 min
By
Toshiki Kaihara
February 3, 2026
by Toshiki Kaihara
February 3, 2026
Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.
June 16, 2026